Evidence map›Paper›PMID 36773217›Full record

ArticleInternational urology and nephrology2023

Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients.

Canan Demir, Ali Doğan Dursun, Gülçin Türkmen Sarıyıldız, Aykut İlker Arslan

Open access · hybridAbstract read
In one paragraph

Article in International urology and nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Canan DemirDepartment of Endocrinology and Metabolism, Atılım Üniversitesi Tıp Fakültesi, Kızılcaşarİncek Gölbaşı, 06830, Ankara, Turkey. cananckdmr@yahoo.com.ORCID http://orcid.org/0000-0001-7459-3636
Ali Doğan DursunDepartment of Physiology, Medical School, Atilim University, and Vocational School of Health Services, Atilim University, Ankara, Turkey.
Gülçin Türkmen SarıyıldızDepartment of General Surgery, Medicana International Ankara Hospital, and Operating Room Services, Vocational School of Health Services, Atılım University, Ankara, Turkey.
Aykut İlker ArslanDepartment of Medical Laboratory, Vocational School of Health Services, Atılım University, Medicana International Ankara Hospital, Ankara, Turkey.
Atilim University · TRÇankaya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo elucidate the association of serum irisin levels with bone mineral density (BMD) and calcium-phosphorus metabolism parameters in chronic kidney disease (CKD) patients and renal transplant recipients (RTRs).

methodsThis is a cross-sectional study involving CKD patients and RTRs. Healthy volunteers served as controls. Age, gender, and dialysis vintage were recorded. Serum irisin, creatinine, glucose, calcium, albumin, 25(OH) vitamin D, ferritin, C-reactive protein, A1C, and lipid profile were studied in all participants. Estimated glomerular filtration rate (eGFR), corrected calcium, and body mass index (BMI) were calculated.

resultsOverall, 49 patients (23 hemodialysis, 26 RTRs) and 25 control subjects were included. In hemodialysis (HD) group, 8 patients (34.8%) had osteoporosis, and 12 patients (52.2%) had osteopenia. In RTR group, 3 patients (11.5%) had osteoporosis, while 15 patients (57.7%) had osteopenia. Among controls, one had osteoporosis, and 7 had osteopenia. There was no significant difference between HD and RTRs; however, osteoporosis rate was significantly lower in control subjects. BMD measurements (femur and lumbar T- and Z-scores) were comparable between HD and RTR groups. Control group DEXA values were similar to RTRs; however, they were significantly higher compared to HD group. 25(OH) vitamin D levels were comparable between the HD and RTR groups, and these were significantly lower compared to values of the control group. Mean serum irisin level was 426.6 ± 191.2 pg/mL in hemodialysis group, 342.6 ± 174.8 in the RTR group, and 208.0 ± 186.1 in controls. Serum irisin levels were similar in RTR and HD groups, but their values were significantly higher compared to controls. When we compared serum irisin levels between patients with and without osteoporosis in the whole cohort and hemodialysis and RTR groups, there was no difference. Serum irisin was positively correlated with lumbar T-score both in hemodialysis and RTR groups.

conclusionOur study is the first in the literature revealing the positive correlation of serum irisin level with femur T-score in RTRs. Serum irisin level was also positively correlated with femur T-scores in hemodialysis patients.

Indexed as

Bone Diseases, MetabolicKidney TransplantationOsteoporosisRenal Insufficiency, ChronicBone DensityCalciumCross-Sectional StudiesFibronectinsHumansRenal DialysisVitamin DCalciumFibronectinsFNDC5 protein, humanVitamin DBone mineral densityChronic kidney diseaseIrisinOsteoporosisRenal transplantation

Identifiers

PMID36773217
PMCPMC10293367
OpenAlexW4320033058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.